• AXT, Inc. recently completed and expanded a follow-on public equity offering of its common stock, raising about US$632.50 million in gross proceeds to fund capacity growth, research and development, and general corporate needs.
• A key use of this capital is to support Beijing Tongmei Xtal Technology Co., Ltd. in increasing indium phosphide substrate production for global export, underscoring AXT’s focus on higher-end semiconductor materials for data and AI applications.
• We’ll now examine how this substantial capital raise to expand indium phosphide capacity could reshape AXT’s investment narrative and risk profile.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 32 best rare earth metal stocks of the very few that mine this essential strategic resource.

AXT Investment Narrative Recap

To own AXT, you need to believe that its specialty in compound semiconductor substrates, especially indium phosphide for data and AI uses, can eventually translate into profitable growth despite recent losses and volatility. The US$632.5 million equity raise strengthens its balance sheet for capacity expansion and R&D, but also adds dilution, so in the near term it sharpens the key catalyst around execution on new InP capacity while heightening the risk that export permits and pricing pressures still hold back returns on this investment.

Among recent announcements, the proposed increase in authorized common stock from 70,000,000 to 120,000,000 shares stands out in light of this offering. It highlights how AXT is giving itself more flexibility to support Beijing Tongmei Xtal Technology’s capacity build out, just as it remains unprofitable with a US$21.3 million net loss in 2025 and relatively thin margins. For investors, the central question is whether this larger capital base ultimately supports the InP driven growth story or extends dilution without a clear payoff.

Yet this expansion also magnifies a risk investors should be aware of if export permits for key substrates remain slow or unpredictable...

AXT's narrative projects $238.5 million revenue and $62.6 million earnings by 2029. This requires 39.3% yearly revenue growth and about an $84 million earnings increase from -$21.4 million today.

Uncover how AXT's forecasts yield a $30.75 fair value, a 60% downside to its current price.

Exploring Other Perspectives

By contrast, the most pessimistic analysts were assuming only about 11 percent annual revenue growth to roughly US$118 million and no profits by 2028, so you should weigh this cautious view against the new capital raise and the possibility that both optimistic and bearish narratives may shift from here.

Explore 5 other fair value estimates on AXT - why the stock might be worth as much as $54.75!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your AXT research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free AXT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate AXT's overall financial health at a glance.

Want Some Alternatives?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.